capecitabine has been researched along with Acute Promyelocytic Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atienza, D; Fisher, SI; Howard, JR; Man, L; Rashidi, A | 1 |
| Li, YJ; Liu, X; Qin, ZF; Shi, J; Sun, YW; Wei, PK; Xiu, LJ; Yan, B; Zhang, YC; Zhou, YQ | 1 |
| Iland, HJ; Mohamed, M; Sharma, S; Supple, SG | 1 |
3 other study(ies) available for capecitabine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma.
Topics: Antimetabolites, Antineoplastic; Bone Marrow; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Rectal Neoplasms | 2014 |
Secondary acute promyelocytic leukemia following chemotherapy for gastric cancer: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Capecitabine; Granulocyte Colony-Stimulating Factor; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Organoplatinum Compounds; Oxaliplatin; Predictive Value of Tests; Remission Induction; Risk Factors; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
Topics: Acute Disease; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Colorectal Neoplasms; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Second Primary; Organoplatinum Compounds; Oxaliplatin; Pancytopenia; Primary Myelofibrosis; Remission Induction; Tretinoin | 2016 |